论文部分内容阅读
目的:观察舒芬太尼复合丙泊酚用于无痛人流麻醉的临床疗效。方法:选择ASA 1～2级自愿接受无痛人工流产手术的患者100例,随机分为舒芬太尼复合丙泊酚组(S组)和芬太尼复合丙泊酚(F组)。S组于丙泊酚给药前舒芬太尼0.15★·kg~(-1)iv,F组于丙泊酚给药前给予芬太尼1μg·kg~(-1)iv。观察两组的麻醉效果,术中生命体征变化、手术时间、苏醒时间、丙泊酚用量及不良反应等。结果:S组的麻醉效果明显优于F组(P<0.05),其他观察指标组间比较无统计学差异。结论:舒芬太尼复合丙泊酚可安全用于无痛人流术的麻醉。
Objective: To observe the clinical efficacy of sufentanil combined with propofol in the painless anesthesia. Methods: A total of 100 ASA patients who underwent painless abortion were randomly divided into two groups: sufentanil combined propofol group (S group) and fentanyl combined propofol group (F group). Group S was given sufentanil 0.15 ~ · kg ~ (-1) before propofol administration, and group F was given fentanyl 1μg · kg ~ (-1) iv before propofol administration. The effects of anesthesia, changes of vital signs, operation time, recovery time, dosage of propofol and adverse reactions in the two groups were observed. Results: The effects of anesthesia in group S were significantly better than those in group F (P <0.05). There were no significant differences among the other groups. Conclusion: Sufentanil combined with propofol can be safely used for painless abortion anesthesia.